NeoGenomics, Inc. (NEO)
9.24
+0.13
(+1.43%)
USD |
NASDAQ |
May 22, 13:50
NeoGenomics EPS Diluted (Quarterly) : -0.1324 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | 3.351 |
| OPKO Health, Inc. | -0.0723 |
| UnitedHealth Group, Inc. | 6.901 |
| Cencora, Inc. | 8.401 |
| Regional Health Properties, Inc. | -0.294 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.11M |
| Revenue (Quarterly) | 186.67M |
| Total Expenses (Quarterly) | 203.78M |
| Enterprise Value | 1.449B |
| Gross Profit Margin (Quarterly) | 41.70% |
| Profit Margin (Quarterly) | -9.16% |
| Earnings Yield | -8.36% |
| Normalized Earnings Yield | -6.305 |